Initial Patients Enrolled in Groundbreaking Tardive Dyskinesia Detection Study
CLEVELAND, Aug. 2, 2023. iRxReminder, LLC, a pioneer in medical adherence technology, is thrilled to announce the enrollment of its first patients in the innovative NIMH-funded study, the TDtect™ Diagnostic. The study leverages... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 2, 2023 Category: Pharmaceuticals Source Type: clinical trials

DCP (RaDiCo Cohort) (RaDiCo-DCP)
Condition:   Primary Ciliary Dyskinesia Intervention:   Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials